Terms: = Liver cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Staging
9 results:
1. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
[TBL] [Abstract] [Full Text] [Related]
2. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival.
Thakral N; Gonzalez T; Nano O; Shin SH; Samuels S; Hussein A
BMC Gastroenterol; 2023 May; 23(1):151. PubMed ID: 37179301
[TBL] [Abstract] [Full Text] [Related]
3. Cone-Beam Computed Tomography-Hepatic Arteriography as a Diagnostic Tool for Small Hypervascular Hepatocellular Carcinomas: Method and Clinical Implications.
Choi YR; Chung JW; Kim JH; Kim HC; Jae HJ; Hur S
Korean J Radiol; 2020 Mar; 21(3):306-315. PubMed ID: 32090523
[TBL] [Abstract] [Full Text] [Related]
4. PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.
Mayerhoefer ME; Prosch H; Beer L; Tamandl D; Beyer T; Hoeller C; Berzaczy D; Raderer M; Preusser M; Hochmair M; Kiesewetter B; Scheuba C; Ba-Ssalamah A; Karanikas G; Kesselbacher J; Prager G; Dieckmann K; Polterauer S; Weber M; Rausch I; Brauner B; Eidherr H; Wadsak W; Haug AR
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):51-60. PubMed ID: 31410538
[TBL] [Abstract] [Full Text] [Related]
5. Sorafenib for Advanced Hepatocellular Carcinoma: A Real-Life Experience.
Longo L; de Freitas LBR; Santos D; Grivicich I; Álvares-da-Silva MR
Dig Dis; 2018; 36(5):377-384. PubMed ID: 30007984
[TBL] [Abstract] [Full Text] [Related]
6. liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty liver Disease.
Angulo P; Kleiner DE; Dam-Larsen S; Adams LA; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Keach JC; Lafferty HD; Stahler A; Haflidadottir S; Bendtsen F
Gastroenterology; 2015 Aug; 149(2):389-97.e10. PubMed ID: 25935633
[TBL] [Abstract] [Full Text] [Related]
7. Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.
op den Winkel M; Nagel D; Sappl J; op den Winkel P; Lamerz R; Zech CJ; Straub G; Nickel T; Rentsch M; Stieber P; Göke B; Kolligs FT
PLoS One; 2012; 7(10):e45066. PubMed ID: 23071507
[TBL] [Abstract] [Full Text] [Related]
8. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
[TBL] [Abstract] [Full Text] [Related]
9. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract] [Full Text] [Related]
